No description available.

3 pp. / Estimates economic impacts of Cooperative Extension's involvement in collaborative rangeland management efforts with a rancher and federal agencies for a Northern Arizona grazing allotment.

No / As the prevalence and incidence of wounds are predicted to increase due to an ageing population with increasing comorbidities, reducing the burden of wounds by optimising healing is seen as a key factor in lowering wound care costs. Inappropriate or delayed treatment adversely affects the time to wound healing, impacting quality of life, and increasing the burden on patients, their families and carers, society and the health economy. Identifying non-healing wounds is vital to cost reduction. Failure to recognise wounds not progressing towards healing increases the subsequent risk of non-healing and places the patient at unnecessary increased risk of wound complications.

Transportation planners, engineers, and administrators face the difficult tasks of prioritizing and justifying proposed investments in transportation infrastructure, particularly as government budgets tighten and alternative investments compete for public funding. One means by which professionals can prioritize and justify large transportation investments is by describing how a proposed project will impact an area’s economy in terms of creating new jobs, raising aggregate income, and increasing business revenues. The report begins by examining the general impact of transportation investments on economic development. Then it surveys various methods and tools that have been proposed for estimating economic impacts. Among these, the TREDIS economic impact model is selected and used to estimate the economic impacts of a current interstate highway project in Texas. / text

No description available.

Class of 2008 Abstract / Objectives: To determine the ecomomic impact of recurrent coagulopathy with crotaline envenomation, using the current standard of care (crotalinae polyvalent immune Fab antivenom), and establish a model of pharmacoeconmic assessment for future studies. Methods: Design of recurrent coagulopathy cost assessment tool including payor costs and patient costs. Using medical and medical billing references, government websites, business websites, and published studies, determine average costs for major variables affecting the cost of recurrent coagulopathy to the payor and the patient. Results: A prospective study has been designed to take place during the historic height of Arizona snake bite season in 2008. Conclusions: Based on previous studies of recurrent coagulopathy an estimated 45-53% of crotaline envenomation patients can expect to experience recurrent coagulopathy after treatment with crotalinae polyvalent immune Fab antivenom. The economic impact to the payor is expected to be high with laboratory costs of $49.45 each, doctor visits costing $66.02, emergency room visits costing $351, and $3563.75 per vial of crotalinae polyvalent immune Fab antivenom. Historically the cost of recurrent coagulopathy to the patient has not been evaluated. Considering lost wages, transportation to and from medical care, and the cost of additional household help and child care, this cost is expected to be great enough to adversely impact individuals and families.

Economic impacts of research that developed Rosette virus-resistant peanut in Uganda are estimated, including the impacts on poverty. The impacts of technology on the cost of production at the household level are determined. This information is used to compute aggregate benefits in an economic surplus model. A probit model is used to identify the determinants of adoption using household data. Information regarding the determinants of adoption is combined with impacts of technology on the cost of production to identify income changes for adopting households. Foster-Greer-Thorbecke poverty measures are used to project changes in poverty for households that adopt. It is estimated that the poverty rate will decline by 1.3 percent as a result of the research. / Master of Science

No description available.

Class of 2009 Abstract / OBJECTIVES: The study’s purpose was determining the economic impact of recurrent coagulopathy with crotaline envenomation using the current standard of care, crotalinae polyvalent immune Fab antivenom (CroFab), and to establish a model of pharmacoeconomic assessment for future studies. METHODS: A recurrent coagulopathy cost assessment tool was designed that included payer and patient costs. This system used medical and billing references, government and business websites, published studies, and average costs for major variables affecting costs of recurrent coagulopathy to the payer and patient. RESULTS: Of the 42 subjects screened during the study period, 13 were eligible, and 5 chose to participate. On average, lab results were the most significant cost to payers ($247.25). No subject required additional vials of CroFab as a result of recurrent coagulopathy and therefore this was the least costly parameter. There were no correlation between lab costs, doctor visits, or ER visits. Lost wages were the highest cost to patients, with an average of $880.85. Household help and child care were the least costly parameters in this study group. The loss to follow-up was a substantial barrier to obtaining the projected number of study subjects. CONCLUSIONS: A major limitation of this study is the small sample size. Therefore, only generalizations can be made by analyzing the data in regards to the true costs of recurrent coagulopathy to patients and payers. Future pharmacoeconomic studies regarding average costs related to crotaline envenomation should consider experimental mortality a significant barrier to obtaining significant results.

PART I The horse numbers of Utah had not been accurately counted since the early 1960's. It was estimated that horse and pony numbers were reaching heights as recorded before the age of tractors and automobiles. Horsemen in Utah were asking for financial assistance for public horse facilities from the Utah legislature. The first part of this study was to survey the horse population to determine an accurate count of Utah horses. PART II In order to be satisfied that the horse industry deserved the spending of public funds, it was necessary to know the economic contribution of the horse industry. Part II information came from a second survey of expenses and incomes of horse owners. This study was to determine the economic importance of the horse industry to the State' s economy. The entire study was to determine the horse population and the impact of the horse industry on the economy of Utah.